Compare iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ Inv Grade Corporate Bond ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $103.55 (market cap $29.10B), while Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B). The key difference: iShares iBoxx $ Inv Grade Corporate Bond ETF is far larger — about 16.5× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ Inv Grade Corporate Bond ETF for 126 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| LQD | VIR | |
|---|---|---|
Market Cap | $29.10B | $1.76B |
Volume | 33,185,388 | 2,764,948 |
Sector | Fixed Income | Health |
52-Week High | $112.91 | $11.78 |
52-Week Low | $101.83 | $5.12 |
Typical Hold Time | 126 Days | 0 Days |
Enterprise Value | — | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LQD trades at $103.52 with a slight 0.95% daily gain, though technical indicators signal bearish momentum with RSI readings showing mixed signals. The ETF faces headwinds from rising bond yields and increased short interest, which grew 53.1% in September according to Defense World on October 1, 2026. Recent dividend payments provide steady income, but the broader bond market selloff creates pressure.
The outlook remains cautious as higher Treasury yields challenge corporate bond valuations. Investment opportunities exist for income-focused investors seeking quality corporate exposure, but risks include persistent yield increases and economic uncertainty. The bearish technical setup suggests near-term pressure may continue.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
